SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-20-000139
Filing Date
2020-11-12
Accepted
2020-11-12 07:14:43
Documents
15
Period of Report
2020-11-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K optn-20201107.htm   iXBRL 8-K 34669
7 GRAPHIC optn-20201107_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-20-000139.txt   211547

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20201107.xsd EX-101.SCH 2423
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT optn-20201107_cal.xml EX-101.CAL 710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT optn-20201107_def.xml EX-101.DEF 1643
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20201107_lab.xml EX-101.LAB 25998
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20201107_pre.xml EX-101.PRE 13731
8 EXTRACTED XBRL INSTANCE DOCUMENT optn-20201107_htm.xml XML 11740
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 201303335
SIC: 2834 Pharmaceutical Preparations